Low ficolin-2 levels in common variable immunodeficiency patients with bronchiectasis.
Clin Exp Immunol
; 179(2): 256-64, 2015 Feb.
Article
em En
| MEDLINE
| ID: mdl-25251245
ABSTRACT
Common variable immunodeficiency (CVID) encompasses a heterogeneous group of antibody deficiencies characterized by susceptibility to recurrent infections and sequelae, including bronchiectasis. We investigated the relevance of the lectin complement pathway in CVID patients by analysing ficolin-2 and ficolin-3 serum levels and genotyping single nucleotide polymorphisms (SNPs) in the FCN2 and FCN3 genes. Our results show that ficolin-2 levels in CVID patients are significantly lower (P < 0.0001) than in controls. The lowest ficolin-2 levels are found in CVID patients with bronchiectasis (P = 0.0004) and autoimmunity (P = 0.04). Although serum levels of ficolin-3 were similar in CVID patients and controls, CVID patients with bronchiectasis again showed lower levels when compared to controls (P = 0.0001). Analysis of single nucleotide polymorphisms in the FCN2 gene confirmed known influences on ficolin-2 serum levels, but did not support a genetic basis for the observed ficolin-2 deficiency in CVID. We found that CVID patients with bronchiectasis have very low levels of ficolin-2. The reason for the deficiency of ficolin-2 in CVID and any possible causal relationship is currently unknown. However, as bronchiectasis is a very important factor for morbidity and mortality in CVID, ficolin-2 could also serve as biomarker for monitoring disease complications such as bronchiectasis.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Bronquiectasia
/
Imunodeficiência de Variável Comum
/
Polimorfismo de Nucleotídeo Único
/
Lectinas
Idioma:
En
Ano de publicação:
2015
Tipo de documento:
Article